Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for July 2023.
-
-
Paper of the MonthEAN NewsResearchFeatured SliderResearch Papers of the Month: Safety and efficacy of rozanolixizumab/zilucoplan in patients with generalised myasthenia gravis (MycarinG and RAISE)
This month we have selected two papers of the month, reporting the results of two randomised, double-blind, placebo-controlled, phase III trials investigating potential therapies for generalised Myasthenia Gravis. -
Paper of the MonthEAN NewsResearchTop ArticlesOne hot topic, one expert, three questions: Kristian Steen Frederiksen on our May 2023 Paper of the Month
Co-Chair of the EAN Scientific Panel on Dementia and Cognitive Disorders answers three key questions about a groundbreaking Alzheimer study. -
Paper of the MonthEAN NewsTop ArticlesFeatured Slider
Research Paper of the Month: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease
Our paper of the month is a phase 1b, randomised, multicentre, placebo-controlled trial, which aims to investigate the safety, pharmacokinetics, and effects of MAPTRx in patients with mild Alzheimer's. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors
Our April paper of the month investigates the association between focal epilepsy and risk of incident dementia compared with patients with stroke or migraine and with healthy controls. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson’s Disease
Our paper of the month presents the results of a prospective, double-blind, randomised, sham-controlled trial involving 16 centres and investigating the safety and efficacy of unilateral FUSA of the globus pallidus internus in patients with medication-refractory idiopathic PD. -
Paper of the MonthEAN NewsResearch
Research Paper of the Month: Headache attributed to SARS-CoV-2 infection, vaccination and the impact on primary headache disorders of the COVID-19 pandemic
Our February Paper of the Month is a narrative review focusing on epidemiology, pathophysiology and treatment of secondary headache following SARS-COV-2 infection and vaccination, and on the impact of COVID-19 pandemic on primary headache disorders. -
Paper of the MonthEAN NewsCOVID-19ResearchCOVID-19 Paper of the Month: Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study
Our paper of the month is a retrospective nationwide cohort study that was carried out to determine the clinical sequelae of long covid for a year after infection in patients with mild disease, and to evaluate its association with age, sex, SARS-CoV-2 variants, and vaccination status. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT)
Our paper of the month reports the results of the ENCHANTED 2/MT trial, performed in 44 Chinese hospitals to compare more intensive with less intensive blood pressure management after successful endovascular thrombectomy. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
COVID-19 Paper of the Month: The decline in stroke hospitalization due to COVID-19 is unrelated to COVID-19 intensity
Our authors of the month compared the occurrence of stroke, utilisation of recanalisation procedures, and demographic parameters during the pandemic period with data from the preceding year. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Lecanemab in Early Alzheimer’s Disease
Our authors of the month report the results of a multicentre phase-3 clinical trial exploring efficacy and safety of Lecanemab in patients with early AD over a follow-up period of eighteen months. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
Covid-19 Paper of the Month: Incidence of Epilepsy and Seizures Over the First 6 Months After a COVID-19 Diagnosis
Our authors of the month conducted a retrospective study of the potential association between COVID-19 and seizures or epilepsy in the six months after infection, using an electronic health records network of 81 million people. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Trial of Endovascular Treatment of Acute Basilar-Artery Occlusion
Our research paper of the month presents the results of the Endovascular Treatment for Acute Basilar-Artery Occlusion (ATTENTION) trial; a multicentre, prospective, randomised and open-label trial, conducted in 36 Chinese centres. -
Paper of the MonthEAN NewsCOVID-19Featured Slider
Covid-19 Paper of the Month: Post-acute sequelae of covid-19 six to twelve months after infection
The authors of our Covid paper of the month conducted this cross sectional study in southern Germany involving people aged 18–65, confirming the existence of a considerable burden of self-reported post-acute symptom clusters -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: EAN/MDS-ES guideline on the treatment of Parkinson’s disease: I. Invasive therapies
This month we have selected the guidelines dedicated to the invasive therapeutic pathways for Parkinson's disease, published jointly by the EAN and the Movement Disorder Society-European Section.